KORU Medical Systems Q4 2023 Adj EPS $(0.02) Beats $(0.04) Estimate, Sales $7.186M Beat $6.944M Estimate
Portfolio Pulse from Benzinga Newsdesk
KORU Medical Systems (KRMD) reported Q4 2023 adjusted EPS of $(0.02), surpassing the $(0.04) estimate, with sales of $7.186M exceeding the $6.944M forecast. However, this represents a 2.16% decrease in sales compared to the same period last year.
March 13, 2024 | 8:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
KORU Medical Systems reported better-than-expected Q4 2023 earnings and sales, but experienced a slight year-over-year decline in sales.
Beating both EPS and sales estimates typically has a positive impact on investor sentiment and stock price in the short term. However, the slight year-over-year sales decline might temper some of the positive momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100